Save the date: Optimum’s 19th Annual Healthcare Investor Conference — 7 October 2027. We look forward to seeing you there! 📸 Were you there? Find your photos and have your say! Find your photos, download your favourites and share them on social media, and don’t forget to tag Optimum so we can see them too. […]
European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease Neuraxpharm Group announced that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, […]
Advanced Medical Solutions Group announced its unaudited interim results for the six months ended 30 June 2026 Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue-healing technologies, announced its unaudited interim results for the six months ended 30 June 2026. Group revenue increased by 4% to £115.5 million and by 3% at […]
New Copenhagen facility to strengthen Europe’s quantum manufacturing capabilities On Friday, Quantum Foundry Copenhagen and the Novo Nordisk Foundation announced plans to establish a new 5,300 m² quantum chip fabrication facility in Copenhagen. The facility will develop and scale the advanced manufacturing equipment needed to produce the next generation of quantum chips and strengthen Europe’s […]
👥London Life Sciences Week 2025 The busiest week in European life sciences is approaching and Optimum and Catalyst Advisors are here to help you maximise your week. Download our events schedule here to plan ahead, connect smart, and make every moment count! If you have any additional events that you would like to be included, […]
